Chiara Gentilini

1.2k total citations
24 papers, 932 citations indexed

About

Chiara Gentilini is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Chiara Gentilini has authored 24 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 16 papers in Immunology and 6 papers in Oncology. Recurrent topics in Chiara Gentilini's work include Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (9 papers). Chiara Gentilini is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (9 papers). Chiara Gentilini collaborates with scholars based in Germany, United States and Netherlands. Chiara Gentilini's co-authors include Volker Lennerz, Catherine Wölfel, Thomas Wölfel, Martina Fatho, Alexander Lifke, Christoph Huber, Roy A. Frye, Lars Fischer, L. Uharek and Olaf Penack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and European Journal of Immunology.

In The Last Decade

Chiara Gentilini

24 papers receiving 917 citations

Peers

Countries citing papers authored by Chiara Gentilini

Since Specialization

Citations

This map shows the geographic impact of Chiara Gentilini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Gentilini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Gentilini more than expected).

Fields of papers citing papers by Chiara Gentilini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Gentilini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Gentilini. The network helps show where Chiara Gentilini may publish in the future.

Co-authorship network of co-authors of Chiara Gentilini

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Gentilini. A scholar is included among the top collaborators of Chiara Gentilini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Gentilini. Chiara Gentilini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Successful Treatment of High-Risk and Refractory Acute Myeloid Leukemia with haploidentical Stem Cell Transplantation Plus NK cell therapy 2010 ·Blood ·Lutz Uharek, Birte Friedrichs, Axel Nogai, Chiara Gentilini, Nadežda Basara, Dietger Niederwieser, Eckhard Thiel	5
2	Mesenchymal Stem Cells Remain Host-Derived Independent of the Source of the Stem-Cell Graft and Conditioning Regimen Used 2009 ·Transplantation ·(unknown), Haifa Kathrin Al‐Ali, (unknown), Christina Franke, Michael Hudecek, Manja Kamprad, (unknown), Michael Cross, Dietger Niederwieser, Chiara Gentilini	44
3	Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia 2008 ·Leukemia ·(unknown), Chiara Gentilini, Thoralf Lange, Catherine Wölfel, Thomas Wölfel, Volker Lennerz, Stefan Stevanović, (unknown), Christian G. Huber, Michael Cross, Dietger Niederwieser	16
4	A Novel Method to Quantify and Characterize Leukemia-Reactive Natural Killer Cells in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation following Conventional or Reduced-Dose Conditioning 2007 ·International Journal of Hematology ·Olaf Penack, Lars Fischer, Andrea Stroux, Chiara Gentilini, Axel Nogai, (unknown), Susanne Ganepola, Thoralf Lange, (unknown), (unknown), Igor W. Blau, Eckhard Thiel, (unknown)	2
5	Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation 2007 ·Bone Marrow Transplantation ·Susanne Ganepola, Chiara Gentilini, (unknown), Thoralf Lange, Kathrin Rieger, Jörg Hofmann, Melanie Maier, Uwe G. Liebert, Dietger Niederwieser, Elisabeth Engelmann, Regine Heilbronn, E. Thiel, L. Uharek	71
6	Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation 2007 ·Bone Marrow Transplantation ·Olaf Penack, Lars Fischer, Andrea Stroux, Chiara Gentilini, Axel Nogai, (unknown), Kathrin Rieger, Susanne Ganepola, W. Herr, Ralf G. Meyer, (unknown), L. Uharek	18
7	The type of ATG matters — Natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius 2007 ·Transplant Immunology ·Olaf Penack, Lars Fischer, Chiara Gentilini, Axel Nogai, (unknown), Kathrin Rieger, Susanne Ganepola, Eckhard Thiel, Lutz Uharek	30
8	NK-Cell Recovery and Immune Reconstitution after Haploidentical Hematopoietic Cell Transplantation Using Either CD34 Selected Grafts and Adoptive NK-Cell Transfer or CD3/CD19 Depleted Grafts: Comparison of Two Strategies for NK Cell Based Immunotherapy. 2007 ·Blood ·Chiara Gentilini, (unknown), (unknown), Axel Nogai, (unknown), (unknown), (unknown), Wichard Vogel, Christoph Faul, Lothar Kanz, Eckhard Thiel, Dietger Niederwieser, Lutz Uharek, Wolfgang Bethge	1
9	Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease 2006 ·Bone Marrow Transplantation ·Daniel Wolff, Stefan Wilhelm, J. Hahn, Chiara Gentilini, Inken Hilgendorf, Beate Steiner, Christoph Kahl, Christian Junghanß, G. Hartung, J. Casper, L. Uharek, Ernst Holler, Mathias Freund	42
10	The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells 2006 ·Experimental Hematology ·Lars Fischer, Olaf Penack, Chiara Gentilini, Axel Nogai, (unknown), Eckhard Thiel, Lutz Uharek	62
11	Vaccination with the WT-1 126-134 Peptide in Patients with Acute Myeloid Leukemia after Allogenic Stem Cell Transplantation. 2006 ·Blood ·Chiara Gentilini, Anne Letsch, (unknown), (unknown), (unknown), Carmen Scheibenbogen, Eckhard Thiel, Lutz Uharek	1
12	Allogeneic hematopoietic cell transplantation following conditioning with⁹⁰Y-ibritumomab-tiuxetan 2005 ·Leukemia & lymphoma ·Thomas Fietz, L. Uharek, Chiara Gentilini, (unknown), Kathrin Rieger, (unknown), D. Sandrock, D. L. Munz, B. Glaß, E. Thiel, Igor Wolfgang Blau	23
13	CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets 2005 ·Leukemia ·Olaf Penack, Chiara Gentilini, Lars Fischer, (unknown), Carmen Scheibenbogen, E. Thiel, L. Uharek	112
14	Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation. 2005 ·Blood ·Ralf G. Meyer, Cedrik M. Britten, Abdo Konur, Klaus Bender, (unknown), Udo F. Hartwig, S. Cindy, Chiara Gentilini, Lutz Uharek, Christoph Huber, Karin Kolbe, Wolfgang Herr	6
15	Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias 2005 ·Critical Reviews in Oncology/Hematology ·Dietger Niederwieser, Chiara Gentilini, Ute Hegenbart, Thoralf Lange, Cornelia Becker, (unknown), (unknown), Wolfram Pönisch, Martin Kristian Raida, Haifa Kathrin Al‐Ali	5
16	The response of autologous T cells to a human melanoma is dominated by mutated neoantigens 2005 ·Proceedings of the National Academy of Sciences ·Volker Lennerz, Martina Fatho, Chiara Gentilini, Roy A. Frye, Alexander Lifke, (unknown), Catherine Wölfel, Christoph Huber, Thomas Wölfel	348
17	CMV-Seropositive Patients Allografted with a CMV-Seronegative Donor Show Delayed or Missing CMV-Specific T-Cell Immune Response and Are at Higher Risk for CMV-Viremia and CMV-Disease. 2005 ·Blood ·Susanne Ganepola, Chiara Gentilini, (unknown), (unknown), Thoralf Lange, Jörg Hofmann, Uwe G. Liebert, Markus Hammer, Elisabeth Engelmann, Dietger Niederwieser, Eckhard Thiel, Lutz Uharek	1
18	WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia. 2005 ·Blood ·Chiara Gentilini, (unknown), Susanne Ganepola, Carmen Scheibenbogen, (unknown), Dietger Niederwieser, Eckhard Thiel, Lutz Uharek	1
19	BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning 2004 ·Leukemia ·Thoralf Lange, Michael W. Deininger, R. Brand, Ute Hegenbart, Haifa Kathrin Al‐Ali, Rainer Krahl, (unknown), L. Uharek, Sabine Leiblein, Chiara Gentilini, Effie W. Petersdorf, Rainer Storb, Dietger Niederwieser	19
20	Transmission of donor illness by stem cell transplantation: should screening be different in older donors? 2004 ·Bone Marrow Transplantation ·Dietger Niederwieser, Chiara Gentilini, Ute Hegenbart, Thoralf Lange, Peter Moosmann, Wolfram Pönisch, Haifa Kathrin Al‐Ali, Martin Kristian Raida, Per Ljungman, Alan Tyndall, Álvaro Urbano-Ispizúa, H M Lazarus, Aloïs Gratwohl	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact